US Patent Issued to Eli Lilly and Co., KeyBioscience on Feb. 17 for "Dual amylin and calcitonin receptor agonists and uses thereof" (Danish, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,566, issued on Feb. 17, was assigned to Eli Lilly and Co. (Indianapolis) and KeyBioscience SA (Lugano, Switzerland).

"Dual amylin and calcitonin receptor agonists and uses thereof" was invented by Tamer Coskun (Carmel, Ind.), Hongchang Qu (Carmel, Ind.), Kim Vietz Andreassen (Frederiksberg, Denmark), Kim Henriksen (Hilleroed, Denmark) and Morten Asser Karsdal (Copenhagen, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure related to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity, and/or dyslipidemia. The disclosure relates to compounds that agonize both the calcit...